04 Dec 2018
Morschhauser et al report the safety and efficacy of lenalidomide in combination with obinutuzumab and establish the recommended phase 2
04 Dec 2018
At first glance, it may not seem like much, a post hoc retrospective analysis of outcomes for patients with different levels
